Cargando…

Characterization of HCV Genotype 5a Envelope Proteins: Implications for Vaccine Development and Therapeutic Entry Target

BACKGROUND: Hepatitis C virus (HCV) is one of the major causes of cirrhosis and hepatocellular carcinoma with an estimation of 185 million people with infection. The E2 is the main target for neutralizing antibody responses and the variation of this region is related to maintenance of persistent inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gededzha, Maemu Petronella, Mphahlele, Maphahlanganye Jeffrey, Selabe, Selokela Gloria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286708/ https://www.ncbi.nlm.nih.gov/pubmed/25598792 http://dx.doi.org/10.5812/hepatmon.23660

Ejemplares similares

Prediction of T-cell epitopes of hepatitis C virus genotype 5a
por: Gededzha, Maemu P, et al.
Publicado: (2014)

Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans
por: Lukhwareni, Azwidowi, et al.
Publicado: (2020)

Hepatitis C Virus Genotype 5 Variability in Treatment-Naïve Patients in South Africa
por: Maunye, Tshegofatso K., et al.
Publicado: (2023)

Genetic characterization of G12P[6] and G12P[8] rotavirus strains collected in six African countries between 2010 and 2014
por: Rakau, Kebareng G., et al.
Publicado: (2021)

Targeting HCV Entry For Development of Therapeutics
por: Wong-Staal, Flossie, et al.
Publicado: (2010)

High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa
por: Tiiti, Teboho Amelia, et al.
Publicado: (2022)

A novel hepatitis B virus recombinant genotype D4/E identified in a South African population
por: Matlou, Mmatsatsi K., et al.
Publicado: (2019)

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
por: Ashfaq, Usman A, et al.
Publicado: (2011)

High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa
por: Tiiti, Teboho Amelia, et al.
Publicado: (2021)

SnapShot: Enveloped Virus Entry
por: Mercer, Jason, et al.
Publicado: (2020)

HIV-1 Diversity in the Envelope Glycoproteins: Implications for Viral Entry Inhibition
por: Araújo, Leonardo Augusto Luvison, et al.
Publicado: (2013)

Cell Entry of Enveloped Viruses
por: Cosset, François-Loic, et al.
Publicado: (2011)

The Association between Symptomatic Rotavirus Infection and Histo-Blood Group Antigens in Young Children with Diarrhea in Pretoria, South Africa
por: Rakau, Kebareng, et al.
Publicado: (2022)

Evaluation of ILEX SelfCerv for Detection of High-Risk Human Papillomavirus Infection in Gynecology Clinic Attendees at a Tertiary Hospital in South Africa
por: Tiiti, Teboho Amelia, et al.
Publicado: (2021)

Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Low seroprevalence of hepatitis E virus in pregnant women in an urban area near Pretoria, South Africa
por: Simani, Omphile E., et al.
Publicado: (2021)

Envelope Protein Dynamics in Paramyxovirus Entry
por: Plattet, Philippe, et al.
Publicado: (2013)

Generation of fluorescent HCV pseudoparticles to study early viral entry events- involvement of Rab1a in HCV entry
por: Bhattacharjee, Chayan, et al.
Publicado: (2022)

A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes
por: Qian, Xi-Jing, et al.
Publicado: (2016)

Hepatitis C Virus (HCV) Envelope Glycoproteins E1 and E2 Contain Reduced Cysteine Residues Essential for Virus Entry
por: Fraser, Johanna, et al.
Publicado: (2011)

HCV entry receptors as potential targets for siRNA-based inhibition of HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Entry inhibitors: New advances in HCV treatment
por: Qian, Xi-Jing, et al.
Publicado: (2016)

Archaeal viruses at the cell envelope: entry and egress
por: Quemin, Emmanuelle R. J., et al.
Publicado: (2015)

Mechanisms of enveloped virus entry into animal cells
por: Klasse, Per Johan, et al.
Publicado: (1998)

The correlation of HCV RNA and HCV core antigen in different genotypes of HCV
por: Xiang, Yu, et al.
Publicado: (2018)

Lysosomal ion channels involved in cellular entry and uncoating of enveloped viruses: Implications for therapeutic strategies against SARS-CoV-2
por: Zhao, Zhuangzhuang, et al.
Publicado: (2021)

Incorporation of apolipoprotein E into HBV–HCV subviral envelope particles to improve the hepatitis vaccine strategy
por: Gomez-Escobar, Elsa, et al.
Publicado: (2021)

Structure and Function of the HIV Envelope Glycoprotein as Entry Mediator, Vaccine Immunogen, and Target for Inhibitors
por: Prabakaran, Ponraj, et al.
Publicado: (2007)

Identification and characterization of key residues in Zika virus envelope protein for virus assembly and entry
por: Ma, Xiao, et al.
Publicado: (2022)

Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response
por: David, Anura, et al.
Publicado: (2021)

Therapeutic vaccines in HBV: lessons from HCV
por: Barnes, Eleanor
Publicado: (2015)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Performance of 6 HCV genotyping 9G test for HCV genotyping in clinical samples
por: Warkad, Shrikant Dasharath, et al.
Publicado: (2018)

Envelope Protein Ubiquitination Drives Zika Virus Entry and Pathogenesis
por: Giraldo, Maria I., et al.
Publicado: (2020)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

HIV envelope: challenges and opportunities for development of entry inhibitors
por: Caffrey, Michael
Publicado: (2011)

Phosphatidylserine receptors: Enhancers of enveloped virus entry and infection
por: Moller-Tank, Sven, et al.
Publicado: (2014)

Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy
por: Teissier, Elodie, et al.
Publicado: (2010)

Entry of Enveloped Viruses into Host Cells: Membrane Fusion
por: Más, Vicente, et al.
Publicado: (2013)

The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection
por: Lindqvist, Richard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r5ok30m8cd3fsbo95b83cro0pv